Autologous Fat Grafting Market

The global Autologous Fat Grafting market size was USD 1.23 billion in 2023, and is calculated at USD 1.36 Billion in 2024. The market is projected to reach USD 3.62 Billion by 2034, and register a revenue 10. 3% over the forecast period (2025-2034).

Premium Insights:

Autologous Fat Grafting (AFG), also known as autologous lipofilling and Autologous Fat Transfer (AFT), is a minimally invasive method to relocate fat extracted from one location to another in a patient’s body. This procedure, follows the Coleman technique, which is a three-stage surgical procedure that involves harvesting, processing, and re-injecting fat to a desired area or location. AFG has been gaining increasing popularity for cosmetic enhancements and in reconstructive procedures, and is widely used particularly for facial rejuvenation to improve appearance. Increasing number of individuals are opting for autologous lipofilling or AFG procedures due to better or safer outcomes and end-results of using fat extracted and introduced from their own body, which greatly reduces potential of rejection as if often the case with synthetic and non-biological material, filers, and grafts or implants and transplants.

Another factor driving steady growth of the global Autologous Fat Grafting (AFG) market is the trend of facial rejuvenation, body contouring, breast augmentation, butt augmentation and high popularity of Brazilian Butt Lift (BBF), and various cosmetic procedures to alleviate conditions associated with aging, such as facial hollowing, wrinkles, facial asymmetries, facial scars, weakened soft tissue support, sagging of skin, and hollowing in the hands. Autologous Fat Grafting is also used in reconstruction surgeries and other procedures for addressing birth deformity, damage to body parts caused by trauma, injury, disease, and medical conditions, and fat grafting promotes healing and tissue repair and rejuvenation.

Expanding application of AFG such as in primary and secondary cicatricial alopecia (CCCA), owing to promising potential to control inflammatory processes, improve signs and symptoms, and increase hair density and diameter, are also expected to support revenue growth of the AFG market over the forecast period. AFG is also an emerging treatment for radiation-induced skin fibrosis (RIF) affecting head and neck function and cosmesis, and has been used in autologous fat transfer for reconstruction of head and neck contour deformity and RIF.

Technological advancements and availability of new and novel treatments and devices and supporting systems are key factors resulting in increasing number of hospitals and clinics, dermatology and cosmetic surgery centers, and ambulatory surgical centers offering cosmetic and reconstructive procedures. This trend has been driving incline in demand for fat grafting systems, liposuction equipment, fat aspiration, harvesting, and processing devices and systems, de-epithelialization devices, along with fat injection cannulas, fat harvesting cannulas, Luer lock infiltrator cannulas, cannula connectors, and single use fat transfer and tubing sets and a variety of others.

Top Autologous Fat Grafting (AFG) Market Drivers and Trends:

• Favorable Outcomes, Low Risks, and Minimally-Invasive Nature: An increasing number of individuals are opting for Autologous Fat Grafting procedures primarily as it is minimally-invasive, presents relatively fewer postoperative complications associated with breast augmentation and other body modification procedures with synthetic filler implants and techniques, and also offers favorable outcomes with rapid recovery times. Also, the option of removing unwanted fat from one area of the body and having it transferred or grafted to a part that is lacking or can be increased to produce desired effects or physical appearance is another key driving factor. The desire to look healthy and fit is also prompting individuals to opt for AFT and liposuction procedures to address fat on tummy, enhance or reduce breast volume, size, and shape, and buttocks and thighs. Among these, breast augmentation and buttock lift, especially Brazilian Butt Lift (BBL), are the most widely sought after, especially in countries in South and North America.
• Plastic Surgery and Cancer-Related Applications: Autologous Fat Grafting is a procedure widely used in cosmetics applications, and in plastic and reconstructive surgery. It is used in hand rejuvenation to improve appearance and texture of skin and reduce visibility of veins if overly noticeable. Also, Autologous Fat Grafting plays a key role in burn and scar contracture, peripheral nerve pathology, tendon adhesion and contracture, thumb CMC arthritis, and congenital hand surgery to address soft tissue deficiency and prevent osteotomy sites from reuniting. Moreover, increasing prevalence of cancer and use of AFG for breast cancer-related applications such as breast-conserving surgery and breast reconstruction, and as a minimally invasive procedure to improve functional and aesthetic outcomes of radiation therapy and surgical resections for malignant head and neck tumors, and as therapeutic intervention to deliver anti-cancer drugs directly to the tumor bed are expected to support growth of this market.
• Addressing Age-Related Conditions: Autologous Fat Grafting is firstly not limited to any particular age group or gender, and can be applicable to anyone, except if not suitable for some in certain situations or circumstances. The favorable and near-permanent outcomes and end results, social media channel influencer effects, as well as the visibility of the results across various online platforms and media channels currently have been resulting in an increasing consumer base of older individuals seeking these procedures. Primary among the procedures in demand are alleviation of accentuated wrinkles and creases in face and body due to volume loss, restoring facial contours and addition of fat to address hollowing and other common signs of aging, and skin enhancements, among others.
• Autologous Fat Grafting (AFG) Market Restraining Factor Insights
• Potential Adverse Effects and Undesired Outcomes: Autologous Fat Grafting if performed by a skilled medical professional may or may not have any side or adverse effects or undesired outcomes. Primary concerns are blood collecting below the skin (hemtoma), tissue death (necrosis), or blood vessel blockage (fat embolism), which occur in some instances, as well as possibility of skin infection (cellulitis), or lumpy scars (contour deformity). Skin irregularities, prolonged edema, graft hypertrophy, fat necrosis, infection, acne, and telangiectasia are other potential adverse effects of Autologous Fat Grafting. Also, outcomes of appropriately conducted procedures can be inconsistent with expectations of some individuals and may not justify the cost and time for procedures. Results can vary owing to factors that determine the survival of transferred fat cells and longevity, settings and devices and tools being used, hygiene conditions and risk of infection due to external factors, as well as potential underlying medical conditions that could have a negative impact on outcomes.
• Cost Factor and Lack of Standardized Guidelines: Overall cost of Autologous Fat Grafting can be high, including pre-procedure consultations, procedure costs, and associated costs for various products and follow-up consultations. Most medical procedures are typically subject to regulations and safety standards. However, there are no standardized guidelines for Autologous Fat Grafting, which can make it difficult to use widely, and this also creates other challenges. Lack of medical insurance cover for cosmetic procedures and enhancements is another factor restraining potential wider preferences, especially in some countries and regions.

Autologous Fat Grafting (AFG) Market Opportunities

• Innovation and R&D For More Efficient AFG Equipment: Companies can invest in R&D and innovation to improve existing fat grafting techniques, systems, and devices, with keen focus on advancing safety and efficiency of fat purification systems and developing more precise processing methods to enhance treatment and procedure outcomes.
• Expanding Market Reach and Portfolio: Entering into strategic agreements and collaborations with healthcare institutions and cosmetic surgery centers and clinics and hospitals can enable wider reach and visibility. Integrating products and offerings to create more extensive portfolio such as offering a comprehensive range of complementary products such as liposuction equipment, cannulas, devices, and accessories can widen access to larger consumer base and drive revenues.
• Technology Integration and Personalized Offerings: Integrating Artificial Intelligence (AI) and analytical tools can enable companies to further advance and innovate equipment, devices, and procedures. This can also aid in developing personalized treatments and plans, gain a competitive edge, and achieve recognition for new approaches.

Autologous Fat Grafting (AFG) Market Segmentation:

By Product Type:

• Integrated Fat Transfer Systems
• Aspiration and Harvesting Systems
• Liposuction Systems
• Fat Processing Systems
• De-epithelialization Devices
• Accessories

By Application:

• Breast Augmentation
• Buttock Augmentation
• Facial Fat Grafting
• Hand Rejuvenation
• Others

By Gender:

• Female
• Male

By Age Group:

• 20-40 Years
• 41-50 Years
• Above 50 Years

By End-User:

• Hospitals
• On-Site Clinics
• Plastic Surgery Centers
• Others

Segment Insights:

By Product Type:

The integrated fat transfer systems segment is expected to account for largest revenue share over the forecast period. Integrated fat transfer systems are in high demand as these systems streamline the entire fat grafting process, from harvesting to reinjection, and offer greater efficiency and safety compared to other systems. Preference is also driven by demand for minimally invasive cosmetic procedures, which offer advantages of shorter recovery times and natural results and outcomes. These systems also minimize fat handling, thereby reducing contamination risks and improving graft survival rates, which are critical for successful outcomes. Advancements in technology has been leading to these systems offering better precision, reduced errors, and enhanced results, and these advantages drive appeal among practitioners in both aesthetic and reconstructive surgeries.

By Application:

The breast augmentation segment is expected to continue to dominate the other application segments in terms of revenue share over the forecast period. Breast augmentation using AFG offers natural-looking results over implants, and the minimally-invasive nature of the procedure is supporting further traction. Besides Autologous Fat Grafting enabling volume enhancement in breast augmentation procedures, it also addresses asymmetry and reconstructive needs post-mastectomy. Rising awareness about the risks of synthetic implants, such as implant rejection and rupture, is also a key factor supporting appeal among more patients for autologous fat transfer.

By Gender:

The female segment is expected to account for largest share of the global Autologous Fat Grafting market over the forecast period. Women are the primary consumers of cosmetic procedures, particularly for breast and buttock augmentation, as well as facial fat grafting for rejuvenation. Increasing demand for body contouring, facial contouring, body enhancement and volume increase such as breast enlargement and Brazilian butt lift, are driven by need to maintain appearance, enhance beauty, and for self-image improvement. Also, need among women for reconstructive surgeries, such as breast reconstruction post-cancer treatment are also key factors supporting revenue growth of this segment.

By Age Group:

The 20-40 years segment among the age group segments is expected to account for largest share. Individuals in this demographic are more likely to undergo cosmetic procedures for enhancement or anti-aging purposes, as applicable. Younger individual among this age range in particular are likely to be inclined towards body contouring, rhinoplasty, and breast and buttock augmentation to achieve desired aesthetics. This age group is also more inclined towards adopting new cosmetic trends, driven by social media and cultural influences, and high focus on self-improvement. Moreover, the success rates and outcomes of Autologous Fat Grafting are more evident in younger individuals due to better skin elasticity and overall health, and this is also a factor that aids in promoting these procedures among this age group.

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

By End-User:

The hospitals segment among the end-user segments is expected to maintain a lead in terms of revenue share over the forecast period. This can be attributed to access to advanced technologies, availability of trained professionals, and provision of comprehensive services in such settings. Hospitals are also capable of addressing rising demand for Autologous Fat Grafting in both aesthetic and reconstructive needs, and are also best equipped to handle complex procedures, including large-scale breast reconstructions and body contouring, among others. Hospitals are also the primary option for patients seeking a high level of safety and regulation compliance, particularly for major surgeries. In addition, the integration of multidisciplinary teams in hospitals ensures that patients receive holistic care, from consultation to post-operative follow-ups, driving more patients to opt for procedures in these settings over smaller clinics.

Regions and Countries

North America

• United States
• Canada
• Mexico

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India

Rest of Asia Pacific

• Latin America
• Brazil
• Argentina

Rest of Latin America

• Middle East & Africa
• Saudi Arabia
• South Africa
• United Arab Emirates
• Israel
• Rest of MEA

Autologous Fat Grafting (AFG) Market Regional Landscape:

Among the regional markets, North America Autologous Fat Grafting market leads in terms of revenue share. The US accounts for a significant revenue share contribution to the North America Autologous Fat Grafting market, and this can be attributed to high adoption rates of advanced cosmetic procedures, presence of advanced healthcare infrastructure and systems and equipment, high prevalence rates of breast cancer, large potential consumer base driven by pop and fitness cultures as well as high focus on enhancing appearance and looks, and favorable healthcare insurance and cover for some cosmetic procedures.

In the Europe Autologous Fat Grafting market, Germany, France, and the UK account for a significantly large revenue share contribution. Factors such as availability of advanced medical facilities, high preference for minimally invasive cosmetic and appearance enhancing procedures, and high prevalence rates of cancer, such as breast cancer and others. The Asia Pacific Autologous Fat Grafting market is expected to register a rapid revenue growth rate in future, owing to large consumer bases in China, Japan, and South Korea with high inclination to enhance appearance and beauty, rising disposable income, and advancements in medical technology and modernization of healthcare infrastructure.

Autologous Fat Grafting (AFG) Market Competitive Landscape:

Company List:

• Plus Therapeutics, Inc.
• Sisram Medical Ltd.
• Integra LifeSciences
• Genesis Biosystems, Inc.
• Tulip Medical
• Sterimedix Limited
• HK Surgical Inc.
• Human Med AG
• Emory Healthcare
• MÖLLER Medical GmbH
• MicroAire Surgical Instruments, LLC
• Alma Lasers
• Innovia Medical
• Grey Medical
• Bimini Health Tech

Competitive Landscape:

The landscape in the global Autologous Fat Grafting market comprises both established and emerging companies offering a range of products and services making the market highly competitive. Companies are focusing on design and development of more advanced equipment and systems, integrating innovative technologies, and exploring opportunities to introduce more efficient, safer, and cost-effective fat grafting procedures.

Companies are also engaging in Research and Development (R&D) and investing in improvements to existing fat grafting techniques, devices, and systems, and also focusing on strategic partnerships, mergers and acquisitions with smaller and tech-driven firms, and also engaging in collaborations with healthcare institutions to drive advancements and innovations. Expansion into emerging markets is also a strategy observed in the market, and companies are capitalizing on data analytics and AI to develop personalized treatment plans as a long-term growth strategy.

Recent Developments

• August 17, 2023: Bimini Health Tech, which is a global leader in innovative medical devices for breast reconstruction and regenerative medicine, announced acquisition of a number of assets of Ideal Implant, Inc., which includes Intellectual Property (IP), regulatory approvals, product inventory, and some manufacturing capacity. With this strategy, Bimini intends to re-position the implant technology for the hospital setting to increase revenue, as well as enter into the plastic and reconstructive surgery market with the addition of breast implant to its existing product portfolio.

• January 10, 2023: intelliFat BOD from Cellmyx, which is a single-use kit designed for harvesting, processing, and transfer of macro, micro, and nano fat tissues, secured FDA 510(k) clearance. Cellmyx is one of the authorities on autologous adipose grafting and transfer, and the IntelliFat Body On Demand tissue harvesting and transfer kit, and the technology used therein are now authorized by US regulators for applications in orthopedic, plastic surgery, and cosmetic surgery. The device are disposable, sterile, and can be used as an alternative or adjunct to surgery for soft tissue defect filling.

Frequently Asked Questions:

Q: What is the global Autologous Fat Grafting (AFG) market size in 2023 and what is the projection for 2034?

A: The global Autologous Fat Grafting (AFG) market size was USD 1.23 billion in 2023 and expected to reach USD 3.26 billion in 2034.

Which regional market accounted for largest revenue share in 2023, and what is the expected trend over the forecast period?

A: North America accounted for largest revenue share in 2023, and is also expected to continue to maintain its lead in terms of growth rate over the forecast period.

Q: Which are the major companies are included in the global Autologous Fat Grafting (AFG) market report?

A: Major companies in the market report are Plus Therapeutics, Inc., Sisram Medical Ltd., Bimini Health Tech, Integra LifeSciences, Genesis Biosystems, Inc., Tulip Medical, Sterimedix Limited, HK Surgical Inc., Human Med AG, Emory Healthcare, MÖLLER Medical GmbH, MicroAire Surgical Instruments, LLC, Alma Lasers, Innovia Medical, Grey Medical.

Q: What is the projected revenue CAGR of the global Autologous Fat Grafting (AFG) market over the forecast period?

A: The global Autologous Fat Grafting (AFG) market is expected to register a CAGR of 10.3% between 2025 and 2034.

Q: What are some key factors driving revenue growth of the Autologous Fat Grafting (AFG) market?

A: Some key factors driving market revenue growth include increasing number of individuals seeking non-invasive and minimally-invasive procedures and approaches to enhance beauty and personal appearance, address deformities, birth defects, damage caused by injury, trauma, disease, and also to fulfill personal desires.